UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients

Clinical microbiology and infection, 2016-04, Vol.22 (4), p.386.e1-386.e3

2016

Volltextzugriff (PDF)

Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjects

Journal of hepatology, 2017, Vol.66 (1), p.S278-S279

2017

Volltextzugriff (PDF)

P0909 : Analysis of natural resistance profile to NS5A replication complex inhibitors in different Hepatitis C genotypes

Journal of hepatology, 2015-04, Vol.62, p.S685-S686

2015

Volltextzugriff (PDF)

Real-Life Experience of Daa-Based Regimens Plus Ribavirin in Cirrhotic Patients Coinfected with HCV and HIV-1

Journal of hepatology, 2016, Vol.64 (2), p.S792-S793

2016

Volltextzugriff (PDF)

P1240 CHARACTERIZATION OF HCV-1 SUBTYPES AND NATURAL RESISTANCE TO PROTEASE INHIBITORS IN LIVER AND PLASMA COMPARTMENTS OF HIV/HCV COINFECTED INDIVIDUALS

Journal of hepatology, 2014-04, Vol.60 (1), p.S502-S503

2014

Volltextzugriff (PDF)

P224 DIFFERENT PROFILE OF NATURAL RESISTANCE TO NS3 PROTEASE INHIBITORS IN HEPATITIS C SUBTYPES 1A AND 1C

Journal of hepatology, 2014-04, Vol.60 (1), p.S140-S141

2014

Volltextzugriff (PDF)

P0588 : Immune response to hepatitis B vaccination in HIV infected individuals with isolated antibodies to HBV core antigen

Journal of hepatology, 2015-04, Vol.62, p.S536-S537

2015

Volltextzugriff (PDF)

Single-Nucleotide Polymorphism-Defined Class I and Class III Major Histocompatibility Complex Genetic Subregions Contribute to Natural Long-term Nonprogression in HIV Infection

The Journal of infectious diseases, 2012-03, Vol.205 (5), p.718-724

2012

Volltextzugriff (PDF)

A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection

Journal of viral hepatitis, 2013-01, Vol.20 (1), p.42-49

2013

Volltextzugriff (PDF)

Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption

Infection, 2010-10, Vol.38 (5), p.417-421

2010

Volltextzugriff (PDF)

1211 AMINO ACID CHANGE IN THE POSITIONS ASSOCIATED WITH PROTEASE INHIBITORS RESISTANCE IS LESS FREQUENT IN GENOTYPE 3 THAN IN GENOTYPE 1 HCV NATURAL STRAIN

Journal of hepatology, 2013-04, Vol.58, p.S492-S492

2013

Volltextzugriff (PDF)

Occult hepatitis B virus infection in a Cohort of HIV-positive patients: Correlation with hepatitis C virus coinfection, virological and immunological features

Infection, 2009-10, Vol.37 (5), p.445-449

2009

Volltextzugriff (PDF)

Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption

Infection, 2011-04, Vol.39 (2), p.121-126

2011

Volltextzugriff (PDF)

1195 TEMPORAL DYNAMIC OF MUTATIONS ASSOCIATED WITH HCV PROTEASE INHIBITORS RESISTANCE IN NATURAL STRAINS OF HIV/HCV COINFECTED INDIVIDUALS

Journal of hepatology, 2012-04, Vol.56, p.S474-S474

2012

Volltextzugriff (PDF)

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV

The Lancet (British edition), 1992-09, Vol.340 (8821), p.697-698

1992

Volltextzugriff (PDF)

T-47 High prevalence of occult hepatitis C virus infection in non alcholic steatohepatitis and cryptogenetic liver diseases

Digestive and liver disease, 2011, Vol.43, p.S91-S92

2011

Volltextzugriff (PDF)

Chronic hepatitis B in children after e antigen seroclearance : Final report of a 29-year longitudinal study

Hepatology (Baltimore, Md.), 2006-03, Vol.43 (3), p.556-562

2006

Volltextzugriff (PDF)

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection

Clinical and experimental immunology, 2003-10, Vol.110 (1), p.9-14

2003

Volltextzugriff (PDF)

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

Scientific reports, 2020-12, Vol.10 (1), p.21291-21291, Article 21291

2020

Volltextzugriff (PDF)

Replication of Hepatitis C Virus in B Lymphocytes (CD19+)

Blood, 1999-08, Vol.94 (3), p.1138-1139

1999

Volltextzugriff (PDF)

T.N.40 OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS (NASH)

Digestive and liver disease, 2010, Vol.42, p.S29-S29

2010

Volltextzugriff (PDF)

Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma

Journal of viral hepatitis, 2006-09, Vol.13 (9), p.574-581

2006

Volltextzugriff (PDF)

Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment

AIDS (London), 2000-07, Vol.14 (11), p.1656-1658

2000

Volltextzugriff (PDF)

[570] MUTATIONS IN THE NATURAL STRAINS OF NS3 PROTEASE DOMAIN THAT CONFER RESISTANCE TO ANTI-HCV PROTEASE INHIBITORS IN HIV/HCV COINFECTED PATIENTS

Journal of hepatology, 2007, Vol.46, p.S217-S217

2007

Volltextzugriff (PDF)

Effect of alpha-fetoprotein on survival in HIV-infected patients with hepatocellular carcinoma

Digestive and liver disease, 2019-10, Vol.51, p.e260-e261

2019

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(89)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients

Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjects

P0909 : Analysis of natural resistance profile to NS5A replication complex inhibitors in different Hepatitis C genotypes

Real-Life Experience of Daa-Based Regimens Plus Ribavirin in Cirrhotic Patients Coinfected with HCV and HIV-1

P1240 CHARACTERIZATION OF HCV-1 SUBTYPES AND NATURAL RESISTANCE TO PROTEASE INHIBITORS IN LIVER AND PLASMA COMPARTMENTS OF HIV/HCV COINFECTED INDIVIDUALS

P224 DIFFERENT PROFILE OF NATURAL RESISTANCE TO NS3 PROTEASE INHIBITORS IN HEPATITIS C SUBTYPES 1A AND 1C

P0588 : Immune response to hepatitis B vaccination in HIV infected individuals with isolated antibodies to HBV core antigen

Single-Nucleotide Polymorphism-Defined Class I and Class III Major Histocompatibility Complex Genetic Subregions Contribute to Natural Long-term Nonprogression in HIV Infection

A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection

Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption

1211 AMINO ACID CHANGE IN THE POSITIONS ASSOCIATED WITH PROTEASE INHIBITORS RESISTANCE IS LESS FREQUENT IN GENOTYPE 3 THAN IN GENOTYPE 1 HCV NATURAL STRAIN

Occult hepatitis B virus infection in a Cohort of HIV-positive patients: Correlation with hepatitis C virus coinfection, virological and immunological features

Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption

1195 TEMPORAL DYNAMIC OF MUTATIONS ASSOCIATED WITH HCV PROTEASE INHIBITORS RESISTANCE IN NATURAL STRAINS OF HIV/HCV COINFECTED INDIVIDUALS

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV

T-47 High prevalence of occult hepatitis C virus infection in non alcholic steatohepatitis and cryptogenetic liver diseases

Chronic hepatitis B in children after e antigen seroclearance : Final report of a 29-year longitudinal study

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

Replication of Hepatitis C Virus in B Lymphocytes (CD19+)

T.N.40 OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS (NASH)

Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma

Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment

[570] MUTATIONS IN THE NATURAL STRAINS OF NS3 PROTEASE DOMAIN THAT CONFER RESISTANCE TO ANTI-HCV PROTEASE INHIBITORS IN HIV/HCV COINFECTED PATIENTS

Effect of alpha-fetoprotein on survival in HIV-infected patients with hepatocellular carcinoma

Suchergebnisse filtern